000 01508 a2200397 4500
005 20250514024833.0
264 0 _c20020507
008 200205s 0 0 eng d
022 _a0168-8510
024 7 _a10.1016/s0168-8510(01)00191-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRuof, Jörg
245 0 0 _aDiffusion of innovations: treatment of Alzheimer's disease in Germany.
_h[electronic resource]
260 _bHealth policy (Amsterdam, Netherlands)
_cApr 2002
300 _a59-66 p.
_bdigital
500 _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAttitude of Health Personnel
650 0 4 _aBudgets
650 0 4 _aCholinesterase Inhibitors
_xeconomics
650 0 4 _aDiffusion of Innovation
650 0 4 _aDrug Utilization
_xeconomics
650 0 4 _aFamily Practice
_xstatistics & numerical data
650 0 4 _aGermany
650 0 4 _aHumans
650 0 4 _aInformation Services
650 0 4 _aInterviews as Topic
650 0 4 _aNeurology
_xstatistics & numerical data
650 0 4 _aPractice Patterns, Physicians'
_xeconomics
650 0 4 _aSampling Studies
700 1 _aMittendorf, Thomas
700 1 _aPirk, Olaf
700 1 _avon der Schulenburg, J-Matthias Graf
773 0 _tHealth policy (Amsterdam, Netherlands)
_gvol. 60
_gno. 1
_gp. 59-66
856 4 0 _uhttps://doi.org/10.1016/s0168-8510(01)00191-9
_zAvailable from publisher's website
999 _c11786925
_d11786925